| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/21/2007 | CN1934252A Thrombin derivatives and medicinal composition containing the same |
| 03/21/2007 | CN1934103A Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 03/21/2007 | CN1934100A Substituted quinazoline or pyridopyrimidine derivative |
| 03/21/2007 | CN1933854A Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient |
| 03/21/2007 | CN1933840A Use of a phenothiazine derivative for preventing and/or treating hearing loss |
| 03/21/2007 | CN1933829A Methods for treating resistant or refractory tumors |
| 03/21/2007 | CN1933823A Use of renin inhibitors in therapy |
| 03/21/2007 | CN1933814A S/O type pharmaceutical preparation and process for producing the same |
| 03/21/2007 | CN1931366A Anticancer biological missile medicine |
| 03/21/2007 | CN1931365A Hcv e1e2 vaccine compositions |
| 03/21/2007 | CN1931175A Medicine composition for preventing and treating farm animal's respiratory tract and digestive tract diseases |
| 03/21/2007 | CN1931113A Intrauterine device of composite material |
| 03/21/2007 | CN1305906C Use of antibodies against specific MHC-Peptide complexes |
| 03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 03/21/2007 | CN1305530C Anti-caries oral compositions |
| 03/21/2007 | CN1305529C Use of IL-18 inhibitors for treating or preventing CNS injuries |
| 03/20/2007 | US7192982 Modulators of peroxisome proliferator activated receptors |
| 03/20/2007 | US7192966 Pharmaceutical composition |
| 03/20/2007 | US7192963 Janus Kinase 3 inhibitors; organ transplant rejection, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autoimmune diseases |
| 03/20/2007 | US7192961 1-Carbonyl-4-(4-quinoline-)-piperazine or 1-carbonyl-4-[4-(1H-quinolin-2-{thio}one)-piperazine derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 03/20/2007 | US7192960 Sodium channel blockers |
| 03/20/2007 | US7192956 Inducing contraception by delivering to a female of child-bearing age a selective estrogen receptor modulator comprising cyclothiocarbamate derivative |
| 03/20/2007 | US7192955 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/20/2007 | US7192949 Anticarcinogenic and antiproliferative agents |
| 03/20/2007 | US7192946 Hyperlipemia agents; bile acid transport inhibitors |
| 03/20/2007 | US7192945 Benzothiazepine derivatives |
| 03/20/2007 | US7192776 mixture of water, creatinine, biocides and optionally urea, having controlled pH and specific gravity, used in urinalysis |
| 03/20/2007 | US7192735 Phosphopantetheinyl transferases and uses thereof |
| 03/20/2007 | US7192733 screening for drugs that inhibit prostaglandin endoperoxidase (PGE) synthase, for use in treatment of inflammation, arthritis, cancer, Alzheimer's disease, in modulating apoptosis, and treating pain |
| 03/20/2007 | US7192718 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM) |
| 03/20/2007 | US7192607 Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulations into mucosal cavities |
| 03/20/2007 | US7192581 Lactobacillus reuteri useful as probiotics |
| 03/20/2007 | US7192580 Purging of cells using viruses |
| 03/15/2007 | WO2007030362A1 Ikk inhibitors for the treatment of endometriosis |
| 03/15/2007 | WO2007030035A1 Agent for correcting stress-inducing neuro-mediator, neuro- endocrine and metabolic disturbances and method for preventing and treating concomitant pathological conditions |
| 03/15/2007 | WO2007029760A1 Pharmaceutical for use in prevention and/or treatment of bowel disease |
| 03/15/2007 | WO2007029642A1 Remedy for osteoporosis with the use of retinoid x receptor-related compound |
| 03/15/2007 | WO2007028821A2 Treatment of autoimmune diseases |
| 03/15/2007 | WO2007010312A3 Use of mmp inhibitors for the preparation of pharmaceutical compositions of cardioprotective effect |
| 03/15/2007 | WO2006136391A3 Treatment of solid tumor disease with combinations comprising imatinib and an efflux pump inhibitor |
| 03/15/2007 | WO2006127284A3 Method of purifying apo-2 ligand/trail using crystallisation in the cold |
| 03/15/2007 | WO2006121560A3 Methods and compositions for treatment of cns disorders |
| 03/15/2007 | US20070060652 Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulators |
| 03/15/2007 | US20070060637 Synergistic combinations of the compound 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and a compound selected from carboplatin, gemcitabine, cisplatin, 5-fluorouracil, cyclophosphamide, etoposide, vincristine, doxorubicin and irinotecan |
| 03/15/2007 | US20070060635 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 03/15/2007 | US20070060605 Compositions and methods for inhibiting platelet activation and thrombosis |
| 03/15/2007 | US20070060595 Novel fused heterocyclic compound and use thereof |
| 03/15/2007 | US20070060571 e.g. 4-(5-(4-Chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl)benzenesulfonamide and nitric oxide donor (S-nitrosothiols, nitrites, nitrates, N-oxo-N-nitrosamines, sabstrate of nitric oxide synthase); analgesics, antiinflammatory agent, wound healing; gastrointestinal disorders; side effect reduction |
| 03/15/2007 | US20070060541 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 03/15/2007 | US20070060521 Inhibition of STAT3 signal transduction for human cancer therapy |
| 03/15/2007 | US20070060511 Combinations of immunosupressive agents for the treatment or prevention of graft rejections |
| 03/15/2007 | US20070060505 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 03/15/2007 | US20070060504 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 03/15/2007 | US20070060503 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 03/15/2007 | US20070060498 2' and 3'-Prodrugs of 1', 2', 3' or 4'-branched beta -D or beta -L nucleosides provide superior results against flaviviruses and pestiviruses, including hepatitis C virus and viruses that replicate through an RNA dependent RNA reverse transcriptase; administering interferons as second antivirus agent |
| 03/15/2007 | US20070059831 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 03/15/2007 | US20070059797 genetic enhancers comprising the nucleotide sequences that elevates transcription of a heterologous coding sequence in a host cell |
| 03/15/2007 | US20070059684 Method of identifying an antiviral agent |
| 03/15/2007 | US20070059381 Treatment of amd with combination of ingredients |
| 03/15/2007 | US20070059352 Therapeutic liposomes |
| 03/15/2007 | US20070059338 Compositions and techniques for localized therapy |
| 03/15/2007 | US20070059298 Method for administering a vaginal care composition |
| 03/15/2007 | DE202007000338U1 Zusammensetzung zur Vorbeugung und Behandlung von Gefäßverschlusserkrankungen Composition for the prevention and treatment of vascular occlusive diseases |
| 03/15/2007 | CA2643205A1 Agent for correcting stress-inducing neuro-mediator, neuro- endocrine and metabolic disturbances and method for preventing and treating concomitant pathological conditions |
| 03/15/2007 | CA2621057A1 Ikk inhibitors for the treatment of endometriosis |
| 03/15/2007 | CA2620554A1 Treatment of autoimmune diseases |
| 03/14/2007 | EP1762610A1 Truncated dance, dance complex and method of using these |
| 03/14/2007 | EP1762271A2 Rehydration composition |
| 03/14/2007 | EP1762255A1 Coated medical devices |
| 03/14/2007 | EP1762248A1 Use of cobalt porphyrins in joint therapy with an immunosuppressant drug for treatment of transplant patients or autoimmune disorders |
| 03/14/2007 | EP1762247A1 The use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissue in humans and animals |
| 03/14/2007 | EP1762243A1 Factor for regulation of neurite growth |
| 03/14/2007 | EP1762236A2 Formulations of alpha adrenergic receptor antagonists and their uses |
| 03/14/2007 | EP1761627A1 Cell-based therapies for ischemia |
| 03/14/2007 | EP1761281A1 Method for treating abnormal cell growth |
| 03/14/2007 | EP1761280A1 Combinations comprising antimuscarinic agents and pde4 inhibitors |
| 03/14/2007 | EP1761279A1 Combinations comprising antimuscarinic agents and pde4 inhibitors |
| 03/14/2007 | EP1761264A1 Treatment with irinotecan (cpt-11) and an egfr-inhibitor |
| 03/14/2007 | EP1761261A1 Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| 03/14/2007 | EP1761258A1 Hypoestoxides, derivatives and agonists thereof for use as stent-coating agents |
| 03/14/2007 | EP1761231A1 Dispenser for progestin used for acute and maintenance treatment of dub |
| 03/14/2007 | EP1631279A4 Combination therapy for the treatment of neoplasms |
| 03/14/2007 | EP1465629B1 5-ht3 receptor antagonists and methods of use |
| 03/14/2007 | EP1461063B1 Treatment of glioblastoma with thymosin-alpha 1 |
| 03/14/2007 | EP1443966B1 Method of preventing or treating benign gynaecological disorders |
| 03/14/2007 | EP1399152B1 Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid mono-ester |
| 03/14/2007 | EP1397681B1 Method for identification of agents for the treatment of diabetes |
| 03/14/2007 | EP1397156B1 Oral administration of parathyroid hormone and calcitonin |
| 03/14/2007 | EP1337276B1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 03/14/2007 | EP1253919A4 Method and compositions for treating an inflammatory disease |
| 03/14/2007 | EP1212068A4 Method of enhancing the efficacy of anti-tumor agents |
| 03/14/2007 | EP1133318B1 Supramolecular complexes containing therapeutic agents |
| 03/14/2007 | EP1071411B1 Topical immunostimulation to induce langerhans cell migration |
| 03/14/2007 | EP1011637B1 Modulation of drug loading in multivesicular liposomes |
| 03/14/2007 | CN1930190A Hyaluronic acid derivative and drug containing the same |
| 03/14/2007 | CN1929880A Bone grafting material, comprising a porous carrier and at least one pyrrolindone, a method for its production and an implant |
| 03/14/2007 | CN1929841A Pharmaceutical composition of (+)-erythro-mefloquine and its use |
| 03/14/2007 | CN1929835A Treatment of aromatase inhibitor therapy-related osteoporosis |
| 03/14/2007 | CN1929737A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 03/14/2007 | CN1928111A Correlation analysis of circulation endothelium progenitor cell and coronary artery pathological changes |